Durect Corp financial data

Symbol
DRRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10240 Bubb Road, Cupertino, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 101 % -15.9%
Quick Ratio 10.1 % +70.8%
Return On Equity -233 % +4.38%
Return On Assets -50.5 % +23.7%
Operating Margin -225 % +57.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31M shares +4.07%
Common Stock, Shares, Outstanding 30.3M shares +33.1%
Entity Public Float 120M USD +11.5%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 31M shares +14.1%
Weighted Average Number of Shares Outstanding, Diluted 31M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.59M USD +9.08%
Research and Development Expense 14.1M USD -58%
Costs and Expenses 27.9M USD -45.6%
Operating Income (Loss) -19.3M USD +54.1%
Nonoperating Income (Expense) 2.27M USD -58.5%
Net Income (Loss) Attributable to Parent -17.1M USD +53.4%
Earnings Per Share, Basic -0.49 USD/shares +67.8%
Earnings Per Share, Diluted -0.59 USD/shares +62.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.09M USD -76.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.02M USD +15.1%
Inventory, Net 2.38M USD -5.75%
Assets, Current 14.4M USD -67.1%
Property, Plant and Equipment, Net 52K USD -59.1%
Operating Lease, Right-of-Use Asset 3.14M USD -28.2%
Goodwill 6.17M USD 0%
Other Assets, Noncurrent 128K USD 0%
Assets 24.1M USD -56%
Accounts Payable, Current 498K USD -62.1%
Accrued Liabilities, Current 4.8M USD -43.8%
Contract with Customer, Liability, Current 178K USD
Liabilities, Current 20.2M USD -45%
Contract with Customer, Liability, Noncurrent 812K USD 0%
Operating Lease, Liability, Noncurrent 1.97M USD -32.8%
Other Liabilities, Noncurrent 676K USD +5.13%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD -16.7%
Retained Earnings (Accumulated Deficit) -605M USD -2.91%
Stockholders' Equity Attributable to Parent 1.22M USD -91.6%
Liabilities and Equity 24.1M USD -56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.77M USD +27%
Net Cash Provided by (Used in) Financing Activities -1.5M USD -115%
Net Cash Provided by (Used in) Investing Activities -887K USD +82%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 30.3M shares +33.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.24M USD -76.4%
Deferred Tax Assets, Valuation Allowance 123M USD +4.89%
Deferred Tax Assets, Gross 124M USD +5.37%
Operating Lease, Liability 4.08M USD +95.2%
Payments to Acquire Property, Plant, and Equipment 33K USD +1000%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.1M USD +53.5%
Lessee, Operating Lease, Liability, to be Paid 4.07M USD -25.8%
Property, Plant and Equipment, Gross 15M USD -22.3%
Operating Lease, Liability, Current 1.31M USD -14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD -5.53%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 903K USD +490%
Lessee, Operating Lease, Liability, to be Paid, Year Three 432K USD -70.1%
Deferred Tax Assets, Operating Loss Carryforwards 83.8M USD +0.59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.6M USD +3.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 227K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 51K USD +15.9%
Share-based Payment Arrangement, Expense 2.02M USD -19.5%
Interest Expense 2.15M USD -0.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%